The cerebrocortical areas in normal brain aging and in Alzheimer's disease: Noticeable differences in the lipid peroxidation level and in antioxidant defense

Neurochemical Research

Volumn 26, Issue 4, 2001, Pages 353-361

  Karelson, Ello ^a   Bogdanovic, Nenad ^b   Garlind, Anita ^b   Winblad, Bengt ^b   Zilmer, Kersti ^a   Kullisaar, Tiiu ^a   Vihalemm, Tiiu ^a   Kairane, Czeslava ^a   Zilmer, Mihkel ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer's disease; Antioxidant defense; Cerebrocortical areas; Lipid peroxidation; Region specificity

Indexed keywords

CATALASE; SUPEROXIDE DISMUTASE;

AGING; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN CORTEX; ENZYME ACTIVITY; FRONTAL CORTEX; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIPID PEROXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0034928785     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010942929678     Document Type: Article

References (57)

1. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease
2. The neurotoxicity of amyloid beta protein in aged primates
3. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer's disease
4. Reactive oxygen species as causal agents in the neurotoxicity of the Alzheimer's disease-associated beta peptide
5. Reactive oxygen species and Alzheimer's disease
6. Oxidative stress in Alzheimer's disease
7. Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation
8. The pathogenesis of senile plaques
9. Glycated tau protein in Alzheimer disease: A mechanism for induction of oxidant stress
10. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease
11. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease
12. An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease
13. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease
14. The antioxidant enzymatic blood profile in Alzheimer's and vascular diseases. Their association and a possible assay to differentiate demented subjects and controls
15. Oxidative-stress associated parameters (lactoferrin, superoxide dismutases) in serum of patients with Alzheimer's disease
16. Cortical feedforward and cortical feedback neural systems in Alzheimer's disease
17. Evolution of Alzheimer's disease related cortical lesions
18. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease
19. Elevated oxidative stress in models of normal brain aging and Alzheimer's disease
20. Free radicals: Important cause of pathologies refer to ageing
21. Glutathione: Toxicologic implications
22. Glutahione, oxidative stress and neurodegeneration
23. Aspects of the structure, function, and applications of superoxide dismutase
24. Cellular injury by oxidants
25. Antioxidant enzymes and their implications in pathophysiologic processes
26. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task forces on Alzheimer's disease
27. The consortium to establish a registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's Disease
28. Diagnostic criteria for Alzheimer's Disease in Multicentre Brain Banking
29. Free radical and antioxidant protocols. Introduction
30. Time course study of oxidative stress during open heart surgery
31. Assay for lipid peroxidation in animal tissues by thiobarbituric acid reaction
32. Effect of low-dose aspirin on the markers of oxidative stress
33. Hypoxia increases the susceptibility of pulmonary artery endothelial cells to hydrogen peroxide injury
34. A simple method for the determination of serum catalase activity and revision of reference range
35. Protein measurement with the Folin phenol reagent
36. Free radical mechanisms in dementia of Alzheimer type and the potential for antioxidative treatment
37. Oxidative stress in Alzheimer's disease
38. Cognitive and behavioral heterogeneity in Alzheimer's disease: Seeking the neurobiological basis
39. How important is oxidative damage? Lessons from Alzheimer's disease
40. Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease
41. Molecular markers of reactive plasticity
42. The heat shock/oxidative stress connection. Relevance to Alzheimer disease
43. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer disease: I. Superior frontal and inferior temporal cortex
44. Heat-shock protein 70 levels in brain of patients with Down syndrome and Alzheimer's disease
45. Molecular forms and regional distribution of cholecytokinin in the central nervous system
46. Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease
47. Increased susceptibility of Alzheimer's disease temporal cortex to oxygen free radical-mediated processes
48. The role of oxidative stress in Alzheimer' s disease
49. Glutahione, oxidative stress and neurodegeneration
50. Brain gamma-glutamyl cysteine synthetase (GCS) mRNA expression patterns correlate with regional-specific enzyme activities and glutathione levels
51. Regional brain activity of free radical defense enzymes in autopsy samples from patients with Alzheimer's disease and from nondemented controls
52. Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex
53. Oxidative posttranslational modifications in Alzheimer disease. A possible pathogenic role in the formation of senile plaques and neurofibrillary tangles
54. Alzheimer's disease and oxidative stress: Implications for novel therapeutic approaches
55. Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative diseases
56. Progression of Alzheimer histopathological changes